Ar­genx’s Vyv­gart Hytru­lo sy­ringe is ap­proved in the US; Opthea to cut 65% of staff

Plus, news about Pro­tag­o­nist Ther­a­peu­tics, Pfiz­er and Keros Ther­a­peu­tics:

Ar­genx wins FDA ap­proval for Vyv­gart Hytru­lo sy­ringe: The sub­cu­ta­neous in­jec­tion, which comes in a more …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER